Together, these results suggest that SIRT2 may directly regulate NK cell function, and they support the working model that increased systemic SIRT2 promotes tumor progression by inhibiting NK cell proliferation, migration, activation, and anti-tumor function. Here, SIRT2 is linked to neoplasm.